IMP dehydrogenase: Inhibition by the anti-leukemic drug, tiazofurin
- 31 December 1988
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 13 (2) , 179-184
- https://doi.org/10.1016/0145-2126(89)90143-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemiaAdvances in Enzyme Regulation, 1988
- Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenaseBiochemistry, 1988
- Purification of IMP dehydrogenase from rat hepatoma 3924ALife Sciences, 1987
- Inosine monophosphate dehydrogenase and myeloid cell maturationBlood, 1987
- Increased Inosinate Dehydrogenase Activity in Mycophenolic acid Resistant Neuroblastoma CellsPublished by Springer Nature ,1986
- Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurinAdvances in Enzyme Regulation, 1984
- Studies on the mechanism of action of 2-β-d-ribofuranosylthiazole-4-carboxamide—VBiochemical Pharmacology, 1984
- Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor InhibitorsNucleosides and Nucleotides, 1982
- Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expressionAdvances in Enzyme Regulation, 1976
- IMP dehydrogenase, an enzyme linked with proliferation and malignancyNature, 1975